Horizon Pharma

Acquired

Amgen - Fighting the World's Toughest Diseases

Dublin, Ireland · Founded 2005

Headquarters
Dublin
Employees
1001–5000
Founded
2005
Business Model
B2B
Acquired by
AmgenOct 2023 · $27.8B

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

Horizon Therapeutics (formerly Horizon Pharma) was a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Founded in 2005 in Illinois, the company built a portfolio of approved therapies including Tepezza for thyroid eye disease, Krystexxa for refractory gout, and Actimmune, serving patients primarily in the United States. Horizon was acquired by Amgen in October 2023 for approximately $27.8 billion, becoming part of Amgen's rare disease portfolio.

Summary

Horizon Pharma is a Biotech company based in Dublin, Ireland, founded in 2005. Investors include Amgen.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Exit History

AcquisitionOct 2023

Sign up to see all 2 events

Funding, valuations, and company events, with amounts and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Horizon Pharma on Indexed.vc
<a href="https://indexed.vc/companies/horizon-pharma"><img src="https://indexed.vc/api/badge/company/horizon-pharma" alt="Horizon Pharma on Indexed.vc" width="260" height="76" /></a>